(Incorporated in Bermuda as an exempted company limited by shares) (Company Registration No. 28925) RESPONSES TO QUERIES FROM SINGAPORE EXCHANGE SECURITIES TRADING LIMITED IN RELATION TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2021 Response to question raised pursuant to the Company s announcement dated 7 June 2021 The board of directors (the Board ) of United Food Holdings Limited (the Company , and collectively with its subsidiaries, the Group ) refers to the Company s announcement dated 7 June 2021 (the Announcement ) with respect to the Unaudited Financial Statements for the financial year ended 31 March 2021 ( FY2021 ). The Board wishes to provide its response to the following question raised by the Singapore Exchange Securities Trading Limited (the SGX-ST ):-
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Todos Medical Receives Notice of Allowance from European Patent Office for Patent Application .
Todos Medical Ltd.April 8, 2021 GMT
NEW YORK, NY, and REHOVAT, ISRAEL, April 08, 2021 (GLOBE NEWSWIRE) via NewMediaWire Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics solutions company, today announced that it has received a notice of allowance (‘Letter of Intent to Grant a Patent’) from the European Patent Office covering the use of the Company’s proprietary Total Biochemical Infrared Analysis (‘TBIA’) method that uses blood (plasma and/or peripheral blood mononuclear cells ‘PBMCs’) to distinguish between patients with benign tumors vs. malignant tumors vs. no tumors (healthy controls).
Todos Medical Provides Corporate Update benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
Todos Medical Applauds Senate and House Passage of the American Recovery Act
March 11, 2021 10:01 ET | Source: Todos Medical Ltd. Todos Medical Ltd.
Todos Medical, Ltd. (OTCQB: TOMDF), an
in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening, diagnosis and immune support, as well as developing blood tests for early detection of cancer and Alzheimer’s disease, today applauded the Senate and House’s passage of the American Recovery Act.
“The US Federal Government is responding appropriately given the scale of the COVID-19 problem we face,” said Gerald Commissiong, President & CEO of Todos Medical. “This bill will dramatically increase funding for the products and services Todos is providing to the lab marketplace, as well as products Todos is developing for SARS-CoV-2 early detection, COVID-19 quarantine release testing and COVID-19 immunity profile monitoring that will support a compreh